Spinocerebellar ataxia type 14 caused by a nonsense mutation in the PRKCG gene

Spinocerebellar ataxia type 14 caused by a nonsense mutation in the PRKCG gene
复制标题

DOI:
10.1016/j.mcn.2019.05.005
复制
发表时间:
2019-07-01
影响因子:
3.5
通讯作者:
Sakai, Norio
Sakai, Norio
中科院分区:
医学3区
文献类型:
--
作者:
Shirafuji, Toshihiko;Shimazaki, Haruo;Sakai, Norio

文献摘要

被引文献

相似文献

脊髓小脑性共济失调14型(SCA 14)是一种常染色体显性遗传性神经退行性疾病,其特征是小脑性共济失调伴肌阵挛、肌张力障碍、痉挛和强直。虽然在SCA 14家族中编码蛋白激酶C γ(PKC γ)的蛋白激酶C γ(PRKCG)基因中已发现错义突变和缺失突变,但无义突变尚未报道。SCA 14的病理机制仍然知之甚少。然而,SCA 14的病理机制报道为功能获得机制和功能丧失机制,而不是显性负性机制。我们确定了PRKCG的c.226C > T突变,通过全外显子组测序,该突变导致患有认知和听力障碍的小脑萎缩患者的PKC γ中的p.R76X。为了探讨我们的病例的病理机制,我们研究了聚集形成,细胞死亡和PKC抑制作用,分别通过共聚焦显微镜,蛋白质印迹切割caspase 3和pSer PKC motif抗体。PKC gamma(R76 X)-GFP具有与野生型(WT)PKC gamma-GFP相同的聚集。PKC γ(R76 X)-GFP比单独的GFP更抑制PKC磷酸化活性。与WT-PKC γ-GFP和GFP相比,它还诱导了COS 7和SH-SY 5 Y细胞的更多凋亡。我们首次报道了SCA 14例PKC γ中p.R76X的患者,他们患有小脑萎缩伴认知和听力障碍。我们的研究结果表明,由于截短肽产生的p.R76X的显性负性机制可能是至少部分负责小脑萎缩。
Spinocerebellar ataxia type 14 (SCA14) is an autosomal dominant neurodegenerative disorder characterized by cerebellar ataxia with myoclonus, dystonia, spasticity, and rigidity. Although missense mutations and a deletion mutation have been found in the protein kinase C gamma (PRKCG) gene encoding protein kinase C gamma (PKC gamma) in SCA14 families, a nonsense mutation has not been reported. The patho-mechanisms underlying SCA14 remain poorly understood. However, gain-of-function mechanisms and loss-of-function mechanisms, but not dominant negative mechanisms, were reported the patho-mechanism of SCA14. We identified the c.226C > T mutation of PRKCG, which caused the p.R76X in PKC gamma by whole-exome sequencing in patients presenting cerebellar atrophy with cognitive and hearing impairment. To investigate the patho-mechanism of our case, we studied aggregation formation, cell death, and PKC inhibitory effect by confocal microscopy, western blotting with cleaved caspase 3, and pSer PKC motif antibodies, respectively.PKC gamma(R76X)-GFP have aggregations the same as wild-type (WT) PKC gamma-GFP. The PKC gamma(R76X)-GFP inhibited PKC phosphorylation activity more than GFP alone. It also induced more apoptosis in COS7 and SH-SY5Y cells compared to WT-PKC gamma-GFP and GFP.We first reported SCA14 patients with p.R76X in PKC gamma who have cerebellar atrophy with cognitive and hearing impairment. Our results suggest that a dominant negative mechanism due to truncated peptides produced by p.R76X may be at least partially responsible for the cerebellar atrophy.